Atlas Trials

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

Clinical trial NCT06222138 · RECRUITING

Trial details

NCT number
NCT06222138
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2024-08-27
Primary completion
2029-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.